The PRISM 2 project aims to develop a quantitative biological approach to the understanding of neuropsychiatric diseases. In this episode Abi Abrahams interviews Professor Martien Kas and Dr. Hugh Marston, where they discussed the aims and legacy of the PRISM 2 project. Conversation covered areas such as industry and academia collaboration, advice for early career scientists, and their hopes for the future in the field of neuropsychiatry. Important links: Prism 2 project: https://prism2-project.eu/en/prism-study/ Innovative Medicine Initiative: https://www.imi.europa.eu/
Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.
Podden och tillhörande omslagsbild på den här sidan tillhör secretariat@ecnp.eu. Innehållet i podden är skapat av secretariat@ecnp.eu och inte av, eller tillsammans med, Poddtoppen.
